Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
Scientific Reports
|
April 8, 2021
Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and <sup>18</sup>F-FMISO PET
Shiliang Huang, Joel E Michalek, David A Reardon, et al.
CA: a Cancer Journal for Clinicians
|
May 23, 2019
The current state of molecular testing in the treatment of patients with solid tumors, 2019
Wafik S El-Deiry, Richard M Goldberg, Heinz-Josef Lenz, et al.
Molecular Carcinogenesis
|
December 25, 2019
PELP1 signaling contributes to medulloblastoma progression by regulating the NF-κB pathway
Yiliao Luo, Mengxing Li, Uday P Pratap, et al.
Breast Cancer Research and Treatment
|
October 15, 2020
KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer
Mei Zhou, Prabhakar Pitta Venkata, Suryavathi Viswanadhapalli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2020
ANG1005, a Brain-Penetrating Peptide-Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases
Priya Kumthekar, Shou-Ching Tang, Andrew J Brenner, et al.
Molecular Cancer Therapeutics
|
July 26, 2023
Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma
Uday P Pratap, Michael Tidwell, Henriette U Balinda, et al.
Nature Communications
|
August 7, 2024
Sacituzumab Govitecan in patients with breast cancer brain metastases and recurrent glioblastoma: a phase 0 window-of-opportunity trial
Henriette U Balinda, William J Kelly, Virginia G Kaklamani, et al.
European Journal of Medicinal Chemistry
|
May 25, 2016
5,10b-Ethanophenanthridine amaryllidaceae alkaloids inspire the discovery of novel bicyclic ring systems with activity against drug resistant cancer cells
Sean Henry, Ria Kidner, Mary R Reisenauer, et al.
Neuro-Oncology
|
December 18, 2019
Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study
Andrew J Brenner, Katherine B Peters, James Vredenburgh, et al.
British Journal of Cancer
|
April 3, 2020
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
David S Hong, Yoon-Koo Kang, Mitesh Borad, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
Scientific Reports
|
April 8, 2021
Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and <sup>18</sup>F-FMISO PET
Shiliang Huang, Joel E Michalek, David A Reardon, et al.
CA: a Cancer Journal for Clinicians
|
May 23, 2019
The current state of molecular testing in the treatment of patients with solid tumors, 2019
Wafik S El-Deiry, Richard M Goldberg, Heinz-Josef Lenz, et al.
Molecular Carcinogenesis
|
December 25, 2019
PELP1 signaling contributes to medulloblastoma progression by regulating the NF-κB pathway
Yiliao Luo, Mengxing Li, Uday P Pratap, et al.
Breast Cancer Research and Treatment
|
October 15, 2020
KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer
Mei Zhou, Prabhakar Pitta Venkata, Suryavathi Viswanadhapalli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2020
ANG1005, a Brain-Penetrating Peptide-Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases
Priya Kumthekar, Shou-Ching Tang, Andrew J Brenner, et al.
Molecular Cancer Therapeutics
|
July 26, 2023
Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma
Uday P Pratap, Michael Tidwell, Henriette U Balinda, et al.
Nature Communications
|
August 7, 2024
Sacituzumab Govitecan in patients with breast cancer brain metastases and recurrent glioblastoma: a phase 0 window-of-opportunity trial
Henriette U Balinda, William J Kelly, Virginia G Kaklamani, et al.
European Journal of Medicinal Chemistry
|
May 25, 2016
5,10b-Ethanophenanthridine amaryllidaceae alkaloids inspire the discovery of novel bicyclic ring systems with activity against drug resistant cancer cells
Sean Henry, Ria Kidner, Mary R Reisenauer, et al.
Neuro-Oncology
|
December 18, 2019
Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study
Andrew J Brenner, Katherine B Peters, James Vredenburgh, et al.
British Journal of Cancer
|
April 3, 2020
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
David S Hong, Yoon-Koo Kang, Mitesh Borad, et al.
Page
of 6